Home

Leukemia

 

ALL-5: Exploring the prognostic significance of minimal residual disease (MRD) in children with ALL
ALL-3: Exploring treatment patterns and outcomes in older adult B-ALL
MDS: Delphi Survey Project: Towards a Core Outcome Set for Myelodysplastic Syndromes
ALL 2: Prognostic Value of IKZF1 Gene Alternations in Adult BCP ALL
MPN-1: Exploring the Impact of Covid-19 on Outcomes in Myeloproliferative Neoplasms
AML: Delphi Survey: Towards a Core Outcome Set for Acute Myeloid Leukemia
MDS-1: Prognostic factors to hypomethylating agents and intensive chemotherapy in higher risk Myelodysplastic Syndromes
CLL-1: Harnessing big data to predict prognosis in Chronic Lymphocytic Leukemia
AML-2: Optimizing Acute Promyelocytic Leukemia Management Using Big Data
AML-1: Use of Big Data to revise treatment strategies in Acute Myeloid Leukemia
ALL 1: Use of Big Data to improve outcomes for patients with Acute Lymphoblastic Leukemia
1-24   25-48